Kewaunee Scientific (NASDAQ:KEQU) CEO Thomas David Hull III Sells 773 Shares

Key Points

• Thomas David Hull III, CEO of Kewaunee Scientific, sold 773 shares of the company for approximately $35,048, reducing his ownership by 1.75% to 43,294 shares valued at about $1.96 million.
• Kewaunee Scientific stock recently increased 1.3% to trade at $44.60, amid ongoing institutional investment interest, with hedge funds holding 32.69% of the company's stock.
• Wall Street analysts have upgraded Kewaunee Scientific's rating from "hold" to "buy", reflecting positive expectations for the company's growth trajectory.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 773 shares of the stock in a transaction dated Friday, September 19th. The stock was sold at an average price of $45.34, for a total transaction of $35,047.82. Following the transaction, the chief executive officer directly owned 43,294 shares in the company, valued at $1,962,949.96. This trade represents a 1.75% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Thomas David Hull III also recently made the following trade(s):

• On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The stock was sold at an average price of $46.00, for a total value of $29,992.00.

Kewaunee Scientific Stock Up 1.3%

NASDAQ:KEQU traded up $0.59 on Monday, hitting $44.60. The stock had a trading volume of 1,396 shares, compared to its average volume of 17,843. Kewaunee Scientific Corporation has a 52 week low of $30.33 and a 52 week high of $71.33. The business's fifty day moving average is $54.51 and its 200 day moving average is $45.55. The company has a quick ratio of 1.63, a current ratio of 2.32 and a debt-to-equity ratio of 0.88. The company has a market cap of $127.99 million, a PE ratio of 10.80 and a beta of 0.75.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. The company had revenue of $71.10 million for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Kewaunee Scientific from a "hold" rating to a "buy" rating in a research report on Saturday, July 5th.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Mink Brook Asset Management LLC purchased a new position in Kewaunee Scientific during the 2nd quarter valued at $370,000. Raymond James Financial Inc. purchased a new position in shares of Kewaunee Scientific during the 2nd quarter worth approximately $60,000. First Trust Advisors LP grew its holdings in shares of Kewaunee Scientific by 3.4% during the 2nd quarter. First Trust Advisors LP now owns 6,726 shares of the technology company's stock worth $395,000 after acquiring an additional 222 shares during the period. Minerva Advisors LLC grew its holdings in shares of Kewaunee Scientific by 5.0% during the 2nd quarter. Minerva Advisors LLC now owns 77,442 shares of the technology company's stock worth $4,501,000 after acquiring an additional 3,677 shares during the period. Finally, De Lisle Partners LLP grew its holdings in shares of Kewaunee Scientific by 6.7% during the 2nd quarter. De Lisle Partners LLP now owns 47,977 shares of the technology company's stock worth $2,811,000 after acquiring an additional 3,029 shares during the period. Hedge funds and other institutional investors own 32.69% of the company's stock.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.